2026年10月30日,70岁的著名科学家维希瓦·迪克西特(Vishva Dixit)在上海举行的世界顶尖科学家论坛上,与袁钧瑛、王晓东、邵峰共同荣获2026年世界顶尖科学家奖“生命科学或医学奖”1。此次获奖旨在表彰其在阐明不同类型程序性细胞死亡分子通路及其对疾病机制调控作用方面的奠基性贡献1。尽管刚刚经历职业变动,迪克西特表示目前正积极筹备成立一家新的生物科技公司,以继续从事科学研究工作1。
迪克西特拥有约44年的科研生涯,于1997年加入基因泰克公司,在该公司工作了29年,期间曾担任分子肿瘤学部门主管及高级研究员1。2026年6月,因基因泰克调整基础研究部门以将资源集中于对患者产生最大影响的工作,迪克西特因此离职1。在谈及跨国科学合作时,迪克西特指出美国从涌入的中国学生中获益巨大,并批评政治因素正在压制科学交流1。
Vishva Dixit, a 70-year-old renowned scientist with approximately 44 years of research experience, is preparing to launch a new biotechnology company following his departure from Genentech 1. In June 2026, Dixit’s basic research department was restructured after he had worked at the pharmaceutical giant for 29 years, having joined in 1997 and served as head of the molecular oncology division and senior researcher 1. Genentech stated that the adjustment was intended to concentrate resources on work with the greatest impact on patients 1. Despite this career shift, Dixit remains committed to scientific inquiry and is actively establishing his own venture 1.
On October 30, 2026, just months after leaving Genentech, Dixit shared the "Life Science or Medicine Award" of the 2026 World Laureates Association Prize with Yuan Junying, Wang Xiaodong, and Shao Feng 1. The award, presented at the World Laureates Forum in Shanghai, honored their foundational contributions to elucidating the molecular pathways of programmed cell death and their regulatory roles in disease mechanisms 1. During interviews related to the award, Dixit emphasized the critical importance of cross-border scientific collaboration 1. He noted that the United States has greatly benefited from Chinese students entering its academic system and criticized political factors for suppressing scientific exchange 1.
评论
还没有评论,欢迎留下第一条。